Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionEULAV Asset Management
Latest Disclosed Ownership21,000 shares
Latest Disclosed Value $ 9,377,340
EULAV Asset Management reports 4.55% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 7, 2026 - EULAV Asset Management filed a 13F-HR form disclosing ownership of 21,000 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $9,377,340 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 22,000 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -4.55% during the quarter. The current value of the position is $9,276,540 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 21,000 -1,000 -4.55 9,377 -5.98 0.3002
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,000 0 0.00 9,974 15.75 0.2660
2025-10-28 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,000 -700 -3.08 8,616 -14.74 0.2002
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,700 -5,800 -20.35 10,106 -26.86 0.2373
2025-04-30 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 28,500 0 0.00 13,817 20.40 0.3413
2025-01-28 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 28,500 -3,000 -9.52 11,477 -21.67 0.2764
2024-11-08 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 31,500 -4,500 -12.50 14,650 -13.17 0.3566
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 36,000 -1,900 -5.01 16,874 6.51 0.4561
2024-05-30 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 37,900 -500 -1.30 15,843 1.40 0.4357
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 38,400 5,000 14.97 15,625 34.53 0.4831
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 33,400 -2,100 -5.92 11,615 -7.03 0.4246
2023-08-10 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 35,500 -2,000 -5.33 12,493 5.73 0.4656
2023-04-27 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 37,500 -4,500 -10.71 11,815 -2.58 0.4658
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 42,000 -6,010 -12.52 12,129 -12.75 0.5206
2022-11-04 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 48,010 -5,998 -11.11 13,901 -8.66 0.6152
2022-07-22 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 54,008 -5,999 -10.00 15,219 -2.82 0.6280
2022-05-10 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 60,007 -19,993 -24.99 15,660 -10.86 0.4661
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 80,000 -28,000 -25.93 17,568 -10.32 0.4432
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 108,000 -34,000 -23.94 19,590 -31.58 0.5169
2021-08-06 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 142,000 -8,000 -5.33 28,631 -11.18 0.7568
2021-04-30 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 150,000 72,000 92.31 32,234 74.85 0.8637
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 78,000 31,500 67.74 18,435 45.69 0.4819
2020-11-05 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 46,500 -20 -0.04 12,654 -6.30 0.3731
2020-08-11 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 46,520 -4,480 -8.78 13,505 11.29 0.4421
2020-04-27 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 51,000 -7,000 -12.07 12,135 -4.44 0.4854
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 58,000 -11,000 -15.94 12,699 8.63 0.4382
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 69,000 -3,000 -4.17 11,690 -11.46 0.4314
2019-08-05 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 72,000 0 0.00 13,203 -1.44 0.4950
2019-05-13 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 72,000 -7,000 -8.86 13,396 2.33 0.5520
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 79,000 -16,000 -16.84 13,091 -28.50 0.6539
2018-10-26 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 95,000 -12,000 -11.21 18,310 0.68 0.7844
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 107,000 -10,000 -8.55 18,186 -4.63 0.8366
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 117,000 -16,000 -12.03 19,069 -4.32 0.9118
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 133,000 8,000 6.40 19,931 4.87 0.9416
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 125,000 -4,000 -3.10 19,005 14.32 0.8978
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 129,000 -8,000 -5.84 16,624 10.97 0.8149
2017-05-11 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 137,000 -5,000 -3.52 14,981 43.21 0.7637
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 142,000 -6,000 -4.05 10,461 -18.95 0.5631
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 148,000 12,000 8.82 12,907 10.33 0.6833
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 136,000 -10,000 -6.85 11,699 0.80 0.6419
2016-05-12 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 146,000 25,000 20.66 11,606 -23.77 0.6478
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 121,000 -1,000 -0.82 15,225 19.83 0.8333
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 122,000 96,000 369.23 12,705 295.79 0.7222
2015-08-17 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 26,000 26,000 3,210 0.1684
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.